Estrogen and stroke: A review of the current literature

Journal of Neuroscience Nursing

Volumn 41, Issue 1, 2009, Pages 18-25

  Carwile, Erin ^a   Wagner, Amy K ^b   Crago, Elizabeth ^c   Alexander, Sheila A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Pittsburgh School of Nursing   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN;

AGE DISTRIBUTION; ANIMAL; CLASSIFICATION; DISEASE MODEL; DRUG SCREENING; ESTROGEN THERAPY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; INCIDENCE; METHODOLOGY; NURSE ATTITUDE; PATIENT SELECTION; PHYSIOLOGY; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SEX RATIO; STROKE;

AGE DISTRIBUTION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; INCIDENCE; NURSE'S ROLE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RESEARCH DESIGN; RISK FACTORS; SEX DISTRIBUTION; STROKE;

EID: 66149120641     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/JNN.0b013e31819345f8     Document Type: Article

References (39)

1. Abramson, B. (2004). Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease: Recommendation statement from the Canadian Task Force on Preventive Healthcare. Canadian Medical Association Journal, 170, 1388-1389.
2. American Stroke Association. (2006). Impact of stroke. Retrieved November 6, 2008, from http://www.strokeassociation.org/presenter.jhtml?identifier=1033
3. Auriat, A., Plahta, W. C., McGie, S. C., Yan, R., & Colbourne, F. (2005). 17β-Estradiol pretreatment reduces bleeding and brain injury after intracerebral hemorrhagic stroke in male rats. Journal of Cerebral Blood Flow and Metabolism, 25, 247-256.
4. Bushnell, C. D., Hurn, P., Colton, C., Miller, V. M., del Zoppo, G., Elkind, M. S. V., et al. (2006). Advancing the study of stroke in women: Summary and recommendations for future research from an NINDS-sponsored multidisciplinary working group. Stroke, 37, 2387-2399.
5. Carswell, H. V. O., Macrae, I. M., Gallagher, L., Harrop, E., & Horsburgh, K. J. (2004). Neuroprotection by a selective estrogen receptor β agonist in a mouse model of global ischemia. American Journal of Physiology. Heart and Circulatory Physiology, 287, H1501-H1504.
6. Choi, Y. C., Lee, J. H., Hong, K. W., & Lee, K. S. (2004). 17B-Estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundamental and Clinical Pharmacology, 18, 547-557.
7. Dubal, D. B., Rau, S. W., Shughrue, P. J., Zhu, H., Y u, J., Cashion, A. B., et al. (2006). Differential modulation of estrogen receptors (ERs) in ischemic brain injury: A role for ERα in estradiol-mediated protection against delayed cell death. Endocrinology, 147, 3076-3084.
8. Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., & Wise, P. M. (1999). Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. Journal of Neuroscience, 19, 6385-6393.
9. Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., et al. (2001). Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proceedings of the National Academy of Sciences of the United States of America, 98, 1952-1957.
10. Falkeborn, M., Persson, I., Terent, A., Adami, H. O., Lithell, H., & Bergstrom, R. (1993). Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Archives of Internal Medicine, 153, 1201-1209.
11. Harrod, C. G., Batjer, H. H., & Bendok, B. R. (2006). Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women. Medical Hypotheses, 66, 736-756.
12. Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., et al., WHI. (2006). Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation, 113, 2425-2434.
13. Hurn, P. D., & Brass, L. M. (2003). Estrogen and stroke: A balanced analysis. Stroke, 34, 338-341.
14. Johnston, S. C., Colford, J. M., Jr., & Gress, D. R. (1998). Oral contraceptives and the risk of subarachnoid hemorrhage: A meta-analysis. Neurology, 51, 411-418.
15. Kessler, I. M., Pacheco, Y. G., Lozzi, S. P., de Araujo, J. A. S., Onishi, F. J., & de Mello, P. A. (2005). Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surgical Neurology, 64(Suppl. 1), S2-S5.
16. Lin, C.-L., Dumont, A. S., Wu, S.-C., Wang, C.-J., Howng, S.-L., Huang, Y.-F., et al. (2006). 17β-Estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Experimental Biology and Medicine, 231, 1054-1057.
17. Liqin Zhao, R. D. B. (2005). Estrogen receptor B as a therapeutic target for promoting neurogenesis and preventing neurodegeneration. Drug Development Research, 66, 103-117.
18. McCullough, L. D., Alkayed, N. J., Traystman, R. J., Williams, M. J., & Hurn, P. D. (2001). Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke, 32, 796-802.
19. Okamoto, K., Horisawa, R., Kawamura, T., Asai, A., Ogino, M., Takagi, T., et al. (2001). Menstrual and reproductive factors for subarachnoid hemorrhage risk in women: A case-control study in Nagoya, Japan. Stroke, 32, 2841-2844.
20. Pedersen, A. T., Lidegaard, O., Kreiner, S., & Ottesen, B. (1997). Hormone replacement therapy and risk of non-fatal stroke. Lancet, 350, 1277-1283.
21. Petitti, D. B., Sidney, S., Quesenberry, C. P., Jr., & Bernstein, A. (1998). Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke, 29, 23-28.
22. Pretorius, M., Guilder, G. P. v., Guzman, R. J., Luther, J. M., & Brown, N. J. (2008). 17β-Estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. Hypertension, 51 (Suppl.), 1190-1196.
23. Rau, S. W., Dubal, D. B., Bottner, M., Gerhold, L. M., & Wise, P. M. (2003). Estradiol attenuates programmed cell death after stroke-like injury. Journal of Neuroscience, 23, 11420-11426.
24. Ribo, M. G., & Grotta, J. C. (2006). Latest advances in intracerebral hemorrhage. Current Neurology and Neuroscience Reports, 6, 17-22.
25. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., et al. for the American Heart Association Statistics Committee and Stroke Statistics. (2008). Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117, e25-e146.
26. Shi, J., Bui, J. D., Yang, S.-H., He, Z., Lucas, T. H., Buckley, D. L., (2001). Estrogens decrease reperfusion-associated cortical ischemic damage: An MRI analysis in a transient focal ischemia model. Stroke, 32, 987-992.
27. Shih, H.-C., Lin, C.-L., Lee, T.-Y., Lee, W.-S., & Hsu, C. (2006). 17β-Estradiol inhibits subarachnoid hemorrhage-induced inducible nitric oxide synthase gene expression by interfering with the nuclear factor κB transactivation. Stroke, 37, 3025-3031.
28. Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., et al. (2001). Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation, 103, 638-642.
29. Simpkins, J. W., Yang, S.-H., Liu, R., Perez, E., Cai, Z. Y., Covey, D. F., et al. (2004). Estrogen-like compounds for ischemic neuroprotection. Stroke, 35 (Suppl. 1), 2648-2651.
30. Tatter, S., Crowell, R., & Ogilvy, C. (1995). Aneurysmal and microaneurysmal angiogram-negative subarachnoid hemorrhage. Stroke, 26, 891-895.
31. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al. (2006). Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, e85-e151.
32. Thorogood, M. (1998). Stroke and steroid hormonal contraception. Contraception, 57, 157-167.
33. Weibers, D. (2001). Stroke-free for life: The complete guide to stroke prevention and treatment. New York: HarperCollins.
34. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Bottner, M., & Rosewell, K. L. (2001). Estradiol is a protective factor in the adult and aging brain: Understanding of mechanisms derived from in vivo and in vitro studies. Brain Research Reviews, 37, 313-319.
35. Yamada, S., Koizumi, A., Iso, H., Wada, Y., Watanabe, Y., Date, C., et al. (2003). Risk factors for fatal subarachnoid hemorrhage: The Japan Collaborative Cohort Study. Stroke, 34, 2781-2787.
36. Yan, J., Chen, C., Lei, J., Yang, L., Wang, K., Liu, J., et al. (2006). 2-Methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Experimental Neurology, 202, 348-356.
37. Yang, S.-H., He, Z., Wu, S. S., He, Y.-J., Cutright, J., Millard, W. J., et al. W. (2001). 17β-Estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism, 21, 174-181.
38. Yang, S.-H., Liu, R. A. N., Wu, S. S., & Simpkins, J. W. (2003). The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Annals of the New York Academy of Sciences, 1007, 101-107.
39. Zhao, L., & Brinton, R. (2006). Select estrogens within the complex formulation of conjugated equine estrogens (Premarin(R)) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer’s disease. BMC Neuroscience, 7, 24.